Major basic protein is a useful marker to distinguish eosinophilic esophagitis from IBD‐associated eosinophilia in children

Abstract

AbstractObjectivesThe incidence of eosinophilic esophagitis (EoE) is 3−5 times greater in patients with inflammatory bowel disease (IBD) compared with the general population. This study aimed to differentiate true EoE from esophageal eosinophilia in IBD patients by evaluating expression of major basic protein (MBP) and interleukin‐13 (IL‐13) in esophageal biopsies.MethodsThis retrospective study included subjects who had an esophagogastroduodenoscopy with esophageal biopsies for IBD work up or suspicion for EoE. Patients were classified into 5 groups: EoE with ≥15 eosinophils per high power field (eos/hpf), EoE‐IBD with ≥15 eos/hpf, IBD eosinophilia with 1−14 eos/hpf, IBD and control groups. Biopsies were stained with MBP and IL‐13 antibodies and the results (% staining/total tissue area), demographic, and clinical findings were compared among the groups.ResultsThe median for MBP staining levels in EoE‐IBD was 3.8 (interquartile range 1.3−23), significantly lower than in EoE at 52.8 (8.3−113.2), but higher than in IBD eosinophilia at 0.2 (0−0.9; p < 0.001) and negligible in the IBD and control groups. IL‐13 expression in EoE was significantly higher only compared with IBD and controls not with EoE‐IBD or IBD eosinophilia. MBP predicted EoE with 100% sensitivity and 99% specificity while IL‐13 had 83% sensitivity and 90% specificity using cutoff point from the cohort without EoE‐IBD patients. Based on MBP cutoff point that distinguished EoE from non EoE, 56% in EoE‐IBD were MBP‐positive whereas 100% in EoE group (p < 0.05).ConclusionsMBP may be an excellent marker in distinguishing true EoE from eosinophilia caused by IBD. Our data implied that MBP together with endoscopic and histologic changes can assist EoE diagnosis in IBD patients.